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Controlled Release of Neurotrophin-3 and Platelet-Derived Growth Factor
From Fibrin Scaffolds Containing Neural Progenitor Cells Enhances Survival
and Differentiation Into Neurons in a Subacute Model of SCI
Philip J. Johnson,* Alexander Tatara,* Alicia Shiu,* and Shelly E. Sakiyama-Elbert*†‡
*Department of Biomedical Engineering, Washington University, St. Louis, MO, USA
†Division of Plastic and Reconstructive Surgery, Department of Surgery,
Washington University School of Medicine, St. Louis, MO, USA
‡Center for Materials Innovation, Washington University, St. Louis, MO, USA
A consistent problem with stem/neural progenitor cell transplantation following spinal cord injury (SCI) is
poor cell survival and uncontrolled differentiation following transplantation. The current study evaluated the
feasibility of enhancing embryonic stem cell-derived neural progenitor cell (ESNPC) viability and directing
their differentiation into neurons and oligodendrocytes by embedding the ESNPCs in fibrin scaffolds contain-
ing growth factors (GF) and a heparin-binding delivery system (HBDS) in a subacute rat model of SCI.
Mouse ESNPCs were generated from mouse embryonic stem cells (ESCs) using a 4−/4+ retinoic acid (RA)
induction protocol. The ESNPCs were then transplanted as embryoid bodies (EBs, 70% neural progenitor
cells) into the subacute model of SCI. ESNPCs (10 EBs per animal) were implanted directly into the SCI
lesion, encapsulated in fibrin scaffolds, encapsulated in fibrin scaffolds containing the HBDS, neurotrophin-
3 (NT-3), and platelet-derived growth factor (PDGF), or encapsulated in fibrin scaffolds with NT-3 and
PDGF with no HBDS. We report here that the combination of the NT-3, PDGF, and fibrin scaffold (with
or without HBDS) enhanced the total number of ESNPCs present in the spinal cord lesion 2 weeks after
injury. In addition, the inclusion of the HBDS with growth factor resulted in an increase in the number of
ESNPC-derived NeuN-positive neurons. These results demonstrate the ability of fibrin scaffolds and the
controlled release of growth factors to enhance the survival and differentiation of neural progenitor cells
following transplantation into a SCI model.
Key words: Spinal cord injury (SCI); Neurotrophin-3 (NT-3); Platelet-derived growth factor (PDGF);
Controlled release; Embryonic stem cell-derived neural progenitor cell (ESNPC)
INTRODUCTION The effectiveness of this spontaneous mechanism for re-
generation may be limited in the case of substantial loss
of spinal cord interneurons at the site of injury and bySpinal cord injury (SCI) is a devastating condition that
results in significant damage to descending and ascending an environment that inhibits the ability of damaged su-
praspinal axons to regenerate over long distances (3).axonal networks, glial and neuronal cell necrosis, and the
formation of an environment that is inhibitory to axonal As a treatment for SCI, stem cells offer a potential
cell source to replace lost cells. Neural progenitor cellsregeneration (13,22). Only limited spontaneous regenera-
tion and functional recovery occurs after SCI. One (NPCs) are stem cells that are restricted to differentiate
into one of the three major neural cell fates (10). Themechanism for spontaneous recovery that has been char-
acterized in rodents is regeneration of damaged supra- limited differentiation potential of NPCs into only neu-
ral cell types has made them an attractive target for SCIspinal cord axons over short distances to form local con-
nections with surviving spinal cord interneurons (3,4,9). treatment. They can be obtained from sites of neurogen-
esis in the fetal or adult brain (e.g., SVZ) and spinalIt is hypothesized that the formation of these local con-
nections facilitates the long-distance relay of supraspinal cord (24), or derived from embryonic stem cells (ESCs)
through induction in culture (2). Prior studies of NPCssignals and restores limited function following injury.
Received April 10, 2009; final acceptance October 1, 2009. Online prepub date: October 9, 2009.
Address correspondence to Shelly Sakiyama-Elbert, Department of Biomedical Engineering, Washington University, Campus Box 1097, One Brook-
ings Drive, St. Louis, MO 63130, USA. Tel: (314) 935-7556; E-mail: sakiyama@wustl.edu
89
90 JOHNSON ET AL.
transplanted into the injured spinal cord have found that transplantation. Furthermore, the addition of the HBDS
to the fibrin scaffolds and GF resulted in an increase intheir survival is often poor and that the cells predomi-
nately differentiate into glia (7,8,21). One hypothesis for the number of ESNPC-derived NeuN-positive neurons.
the predisposition for glial differentiation following
MATERIALS AND METHODStransplantation into the injured spinal cord was given by
Embryonic Stem Cell Culture and EmbryoidCao et al., who have shown that the environment in the
Body Formationspinal cord following injury inhibits differentiation of
NPCs into a neuronal fate (6). The differentiation of CE3 mouse ESCs genetically engineered to express
transplanted NPCs into astrocytes may be problematic green fluorescent protein (GFP) under the β-actin pro-
because reactive gliosis is believed to be an inhibitor of moter were obtained from D. Gottlieb and were cultured
regeneration (23,26). SCI treatments utilizing stem cells in T25 flasks (Fisher, Pittsburgh, PA) coated with a
are currently limited by poor cell survival and uncon- 0.1% gelatin solution (Sigma, St. Louis, MO) in the
trolled differentiation in part as a result of the transplan- presence of 1000 U/ml leukemia inhibitory factor (LIF;
tation environment. Chemicon, Temecula, CA) and 10−4 M β-mercaptoetha-
Nakamura et al. showed that given a favorable envi- nol (BME; Invitrogen, Grand Island, NY) to maintain
ronment (injured neonatal spinal cord), transplanted their undifferentiated state. These cells were grown in
NPCs can survive, integrate with host tissue, and differ- complete media consisting of Dulbecco’s modified Ea-
entiate into neurons and oligodendrocytes (25). Further- gle media (DMEM) (Invitrogen) supplemented with
more, they found that repopulation of the injured spinal 10% newborn calf serum (NBCS; Invitrogen), 10% fetal
cord with neurons and oligodendrocytes contributed sig- bovine serum (FBS, Invitrogen), and 0.3 M of each of
nificantly to plasticity and regeneration that resulted in the following nucleosides: adenosine, guanosine, cyto-
functional recovery. While the environment of the in- sine, thymidine, and uridine (Sigma) and passaged at a
jured neonatal spinal cord, which is conducive to regen- ratio of 1:5 every 2 days.
eration, differs significantly from the more inhibitory Undifferentiated ESCs were induced to form EBs
adult spinal cord (7), these results illustrates that NPC- containing ESNPCs using a 4−/4+ RA induction proto-
derived neurons and oligodendrocytes can have a posi- col (2). ESCs were cultured in 100-mm petri dishes
tive effect on functional recovery. The survival of trans- (Fisher) coated with a 0.1% agar solution (MidSci, Saint
planted NPCs following SCI can be enhanced using GF Louis, MO) in complete media in the absence of LIF
delivered over 7 days from an osmotic pump (18). In and BME for 4 days. RA (500 nM; Sigma) was added
this study, the survival of transplanted cells was en- to the complete media for the final 4 days of culture.
hanced but the transplanted NPCs adopted a glial fate. The media was changed every other day during induc-
The difficulty of promoting the survival of transplanted tion. The resulting EBs contained 70% nestin-positive
NPCs and controlling their differentiation into neurons NPCs (31).
has led our group to investigate a novel scaffold for
Tissue Engineered Fibrin Scaffold Preparationtransplantation.
The current study evaluated a method to enhance All materials were purchased from Fisher Scientific
(Pittsburgh, PA) unless otherwise noted. Fibrin scaffoldsESNPC viability and direct their differentiation into a
population of neurons and oligodendrocytes follow- were made as described previously by mixing the fol-
lowing components: human plasminogen-free fibrinogening transplantation into a subacute model of SCI (17).
Embryonic stem cell-derived neural progenitor cells containing Factor XIII (10 mg/ml, Sigma), CaCl2 (5
mM), and thrombin (12.5 NIH U/ml, Sigma) in Tris-(ESNPCs) were derived from mouse ESCs using a 4−/
4+ RA induction protocol (2). The ESNPCs were encap- buffered saline (TBS, 137 mM NaCl, 2.7 mM KCl, 33
mM Tris, pH 7.4) (27). The bidomain affinity peptidesulated in fibrin scaffolds with or without a heparin-
binding delivery system (HBDS) that allowed for the for the HBDS, denoted ATIII, was synthesized by stan-
dard solid phase Fmoc chemistry as described pre-controlled delivery of neurotrophin-3 (NT-3) and plate-
let-derived growth factor (PDGF) (27). Fibrin scaffolds viously (27). In scaffolds containing the HBDS, ATIII
peptide (0.25 mM) and heparin (6.25 µM, Sigma, so-containing the HBDS have been shown to control the
release of NT-3 and PDGF in vitro (32). At 2 weeks dium salt from porcine intestinal mucosa) were added to
the fibrin polymerization mixture. In scaffolds contain-following transplantation, the treated spinal cords were
harvested and evaluated for ESNPC viability, differenti- ing ESNPCs, the EBs were added directly to the poly-
merization mixture prior to polymerization. Polymerizedation, and host spinal cord response. We report here that
transplanting ESNPCs within fibrin scaffolds containing fibrin scaffolds (10 µl in volume) were formed by eject-
ing the polymerization mixture from a 20-µl pipette tipgrowth factor (GF) enhanced the total number of donor-
derived cells present in the spinal cords at 2 weeks after such that a sphere of the mixture formed on the tip of
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the pipette. The sphere was then allowed to polymerize or fibrin sphere containing 10 EBs with 125 ng NT-3
and 20 ng PDGF-AA with no HBDS (10EB + GF noon the pipette tip for 5 min prior to implantation into
the injury site. A second 20-µl polymerization solution DS, n = 8) were placed in the injury site. The untreated
control group received the same surgical removal of scardevoid of EBs was then injected directly onto the sphere
already in the injury site and allowing it to polymerize tissue but no treatment with fibrin scaffolds or cells. Ta-
ble 1 lists the experimental sample size for each analysisin the lesion site and stabilize the sphere in the injury
site. technique used in the study.
Animals were given cefazolin (15 mg/kg, twice a
In Vivo Studies: Dorsal Hemisection Subacute SCI day) for 5 days following each surgical procedure as a
and Scaffold Implantation prophylactic against urinary tract infections. Bladders
were expressed manually twice a day until they regainedAll experimental procedures on animals complied
with the Guide for the Care and Use of Laboratory Ani- bladder control, approximately 5–6 days post-initial in-
jury. Animals with transplanted ESNPCs were immunemals and were performed under the supervision of the
Division of Comparative Medicine at Washington Uni- suppressed with 10 mg/kg of cyclosporine A (Novartis,
East Hanover, NJ), because mouse ESCs were beingversity. Long-Evans female rats (250–275 g, Harlan, In-
dianapolis, IN) were anesthetized using 4% isoflurane transplanted into rats. The animals were euthanized at
the end of each study using an overdose of Euthasolgas (Vedco Inc., St Josephs, MO). The skin and muscle
overlying the spinal column were incised and dissected (Virbac, France). After transcardial perfusion using 4%
paraformaldehyde (Sigma), spinal cords were dissectedaway from the spinal column. Clamps attached to the
spinous processes and a rigid frame was used to immo- and postfixed in 4% paraformaldehyde solution over-
night. The cords were then cryoprotected in a 30% su-bilize the spinal column. A dorsal laminectomy was per-
formed using fine rongeurs at level T-9 to expose the crose solution in phosphate-buffered saline (PBS) in
preparation for frozen sections. The spinal cord was em-spinal cord. A lateral slit in the dura was made, and
microdissection scissors mounted to a micromanipulator bedded in Tissue-Tek OCT compound Mounting Media
(Sakura Finetek, Torence, CA) and cut into 20-µm sagit-were lowered into the spinal cord 1.2 mm from the dor-
sal spinal cord surface. Using the microdissection scis- tal sections using a cryostat.
sors, a lateral incision was made to form a complete
Immunohistochemistrydorsal hemisection of the spinal cord. Finally the micro-
dissection scissors were run through the incision to as- Immunohistochemistry was used to assess the differ-
entiation of the transplanted ESNPCs and morphologicalsure the hemisection was complete. The cord was then
covered with a piece of artificial dura (generous gift of aspects of the spinal cord from each experimental group.
Sections were washed with PBS and permeabilized withSynovis Surgical Innovations, St. Paul, MN), the mus-
cles were sutured with degradable sutures, and the skin 0.1% Triton X-100 for 5 min. After washes in PBS, the
sections were blocked with 10% bovine serum albuminwas stapled close. Two weeks following initial injury
the lesion was reexposed, and scar tissue was removed (BSA, Sigma) and 2% normal goat serum (NGS,
Sigma). Primary antibodies against glial fibrillary acidicfrom the wound site of control and experimental groups
in preparation of fibrin scaffold transplantation.
A 2-week study was performed to evaluate the sur-
Table 1. Experimental Sample Size (N) for Eachvival, differentiation, and host response to ESNPCs
Experimental Analysistransplanted in tissue engineered fibrin scaffolds.
ESNPCs were transplanted as EBs based on previous Stereology and
work (30). Each EB contains approximately 10,000 Experimental Differentiation Macrophage
ESNPCs. A 1-week study was previously performed to Groups Analysis (N)* Analysis (N)
evaluate the effect of cell number on survival and a dose
End point 2 weeks 2 weeksof 10 EBs was found to elicit robust ESNPC survival
10EB no Fibrin 6 6and proliferation after transplantation (unpublished
10EB + Fibrin 8 8data). As described above, scar tissue was removed and 10EB + DD + GF 8 8
either no treatment (control, n = 6), a fibrin sphere alone 10EB + GF no DS 8 8(Fibrin, n = 6), 10 EBs placed directly in the lesion site Control — 6
with no fibrin (10EB no Fibrin, n = 6), a fibrin sphere Fibrin — 6
containing 10 EBs (10EB + Fibrin, n = 8), a fibrin
Includes rats with no ESNPCs after 2 weeks.sphere containing 10 EBs and HBDS with 125 ng NT-3
*Stereology and differentiation analysis was not performed on Control(Peprotech, Rock Hill, NJ), and 20 ng PDGF-AA (R&D and Fibrin groups because ESNPCs were not transplanted in these
groups.Systems, Minneapolis, MN) (10EB + DS + GF, n = 8),
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protein (GFAP, rabbit polyclonal, recognizing astro- ture of the lesion. To ensure accurate quantification of
GFP-positive ESNPCs, control sections that did not re-cytes, 1:4; ImmunoStar, Hudson, WI), neuronal class III
β-tubulin (Tuj1, mouse monoclonal, recognizing neu- ceive cell transplants were imaged under the same con-
ditions to account for auto fluorescence. The area ofrons, 1:200; Covance Research Products, Berkeley, CA),
ED1 (mouse monoclonal, recognizing macrophages/ GFP+ pixels (representing ESNPC-derived cells), and
the area of pixels positive for both GFP and one of themicroglia, 1:100; Serotec, Oxford, UK), anti-oligoden-
drocyte marker O4 (O4, mouse monoclonal, recognizes five neural markers (Tuj1, GFAP, O4, or nestin; repre-
senting potential ESNPC-derived cell types) was mea-oligodendrocytes, 1:200; Millipore), anti-nestin (nestin,
mouse monoclonal, recognizes NPCs, 1:200; Millipore), sured in each section using the binary image processing
software Ia32 (Leco, St. Joseph, MI) (Fig. 1). An aver-anti-neuronal nuclei (NeuN, mouse monoclonal, recog-
nizes mature neurons, 1:500; Millipore), and anti-SSEA- age area across all the sections for each animal was then
calculated to determine the average area of marker ex-1 (SSEA-1, mouse monoclonal, recognizes mouse ESCs,
1:50; Millipore) were used to evaluate each section. Fi- pression. An intensity threshold was set so that only pix-
els positive for the given marker were quantified withinnally, appropriate secondary antibodies (Alexa Fluor
555, and 647 conjugated, 1:300; Invitrogen, Carlsbad, the lesion. This analysis was performed in the place of
stereology because the nature of the tight organizationCA) diluted with 2% NGS were used and each section
was stained with Hoechst nuclear stain (1:1000; Molecu- of the transplanted cells and the markers used made de-
lineation between adjacent cells impossible (Fig. 2). An-lar Probes).
imals in which ESNPCs were not seen in the spinal cord
Stereological Analysis of Transplanted Cells at the end of 2 weeks were included in the analysis as
0. Table 1 is a list of the experimental sample size forSagittal sections of the frozen spinal cords were
taken, resulting in 100 frozen serial sections. Every each analysis technique used in the study and indicates
the inclusion of 0 for groups with no ESNPCs.12th section was then analyzed using stereological tech-
niques, resulting in 8 sections from each animal being
Macrophage/Microglia Profile Analysisanalyzed. Stereological cell counts of GFP+ cells to de-
termine cell survival were performed on the 12th equi- To assess the tissue response to the transplanted
ESNPCs, the lesion area was imaged at 40× magnifica-distant frozen section from each animal and counter-
stained with the nuclear dye Hoechst. To determine the tion and individual 40× images of the lesion area were
spliced together to yield a complete picture of the lesionnumber of GFP+ mature neurons present at the end of
the 2-week study, stereological cell counts of GFP/ area and surrounding intact cord. ED1 staining of mac-
rophages and microglia was analyzed surrounding theNeuN double-positive cells was performed on the 12th
equidistant frozen section from each animal. All stereo- lesion site in six serial sections spaced 200 µm apart
from each rat to evaluate the tissue response to the fibrinlogical counts were performed using the Stereo Investi-
gator Software (Version 7, MBF Biosciences, Williston, scaffolds. Macrophage/microglia response was analyzed
by using a program written in the Matlab Image Process-VT) and verified with a Gunderson coefficient of error
less than 0.1. Animals in which ESNPCs were not seen ing Toolbox (Mathworks, Natick, MA) as described pre-
viously (17). The program allowed the user to define thein the spinal cord at the end of 2 weeks were included
in the analysis as 0. Table 1 is a list of the experimental lesion border based on GFAP staining. Based on this
border, the program generates line profiles of a specificsample size for each analysis technique used in the study
and indicates the inclusion of 0 for animals with no distance spaced 5 µm apart originating at the lesion bor-
der and preceding either rostrally or caudally from theESNPCs.
border. The program then analyzed the pixel intensity
Differentiation Analysis of Transplanted ESNPCs along these lines and extracted relative ED1 fluores-
cence intensity as a function of distance from the glialSagittal sections of the frozen spinal cords were
taken, resulting in 100 frozen serial sections. Every scar border (16). The analysis yielded a profile for each
sample. The ED1 intensity was normalized by a positive12th section was then analyzed resulting in 8 sections
from each animal being analyzed. The lesion area of control from each stained section. To concisely convey
these data, the normalized intensity was displayed at dis-every 12th serial spinal cord section was imaged at 100×
magnification using an Olympus IX70 microscope tances of 0, 50, 100, 200, and 400 µm rostral (−) and
caudal (+) to the lesion border. In Figure 3, the −0 and(Olympus America, Melville, NY) and Magnafire Cam-
era (Optronics, Goleta, CA). Imaging resulted in multi- +0 distance values indicate the normalized ED1 inten-
sity directly at the border of the lesion and the adjacentple 100× images per section that encompassed the entire
lesion site, which were later spliced together using Pho- spinal cord tissue both rostral (−) and caudal (+) to the
lesion. The other distances, 50, 100, 200, and 400 µmtoshop (Adobe, San Jose, CA) to yield a complete pic-
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Figure 1. The figure depicts the average area of expression analysis used to analysis differentiation in the current study. Fluorescent
images of transplanted ESNPCs shown here stained with β-tubulin (Tuj1, red, neurons) and green fluorescent protein (GFP, green)
were taken at 10× magnification. The images were then separated into images of different colored channels (red, green, and blue)
representing the different immunohistochemical stains (the red channel gives an image of Tuj1 staining and the green channel gives
the picture of GFP staining). The separated images were then thresholded to identify areas that were positively stained for the given
marker. The GFP image was then processed to remove any artifacts that might result in autofluorescence and thus could skew the
measurement (example shown here is the edge of an air bubble in the mounting solution). The processed images were then merged
using a Boolean operation that transfers those pixels that are positive for both GFP and Tuj1 into a merged image (light green
pixels in merged image). The area of these pixels was then quantified to determine an area of expression of the given marker, in
this case for Tuj1/GFP coexpression. Scale bar: 100 µm.
rostral (−) and caudal (+), extend out from the 0 dis- Statistical Analysis
tance. There are two 0 distance values because the injury All statistics were performed with analysis of vari-
along the rostral to caudal axis is discontinuous and thus ance (ANOVA, planned comparison post hoc test) using
there is a rostral value (−0) and a caudal value (+0). Statistica (StatSoft, Tulsa, OK). Significance was deter-
mined to be p < 0.05. The statistical software automati-
cally performs a Bonferroni correction for multiple com-
parisons.
RESULTS
Stereological Analysis of the In Vivo Survival
of ESNPCs and Neuronal Differentiation
The extent of ESNPC survival at 2 weeks after trans-
plantation depended on the method of transplantation
and the presence of GF. In the 10EB no Fibrin group
only 50% of the animals were found to have any GFP+
cells present compared to 75% of the 10EB + Fibrin
group, 100% of the 10EB + DS + GF group, and 89%
of 10EB + GF no DS group (Table 2). The overall sur-
vival of the transplanted ESNPCs was quantified for
each group using stereological counts of GFP+ cells.
There was an increase in the number of GFP+ cells when
the ESNPCs were transplanted within fibrin scaffoldsFigure 2. An image of transplanted ESNPCs after 2 weeks
stained with β-tubulin III for neurons in red, GFP for trans- with GF (10EB + DS + GF and 10EB + GF no DS)
planted ESNPCs in green, and Hoechst nuclear stain in blue. compared to the ESNPCs implanted into the lesion site
The image shows the formation of rosette-like structures alone (10EB no Fibrin, n = 3) and ESNPCs embedded
within the transplanted EB that suggest early neural differenti- in fibrin with no GF (10EB + Fibrin, n = 6) (p < 0.05)ation. The image also shows the congested nature of the trans- (Fig. 4A). The estimated number of GFP+ ESNPCs afterplants that makes accurate stereological counts of certain cell
markers impossible. Scale bar: 100 µm. 2 week suggests that the transplanted cells are not only
94 JOHNSON ET AL.
Figure 3. Effect of ESNPCs on macrophage/microglia staining. The tissue response to the ESNPCs and fibrin scaffolds containing
ESNPCs was analyzed by measuring the intensity of ED1 staining as a function of distance from the lesion border. The analysis
yielded an ED1 profile for each experimental group that was normalized by a positive control. (A) ED1 profile for the control
(open bars, n = 6) and 10EB no fibrin group (filled bars, n = 6) 2 weeks following implantation. The normalized intensity is
displayed at distances of 0, 50, 100, 200, and 400 µm rostral (−) and caudal (+) to the lesion border. The 10EB no fibrin group
exhibited a significant decrease in normalized ED1 intensity at points adjacent to the lesion border (*p > 0.05 vs. control at same
distance). (B) ED1 profile for the control (open bars, n = 6) and 10EB + Fibrin group (filled bars, n = 8) 2 weeks following
implantation. The 10EB + Fibrin group exhibited a significant decrease in normalized ED1 intensity at points adjacent to the lesion
border (*p > 0.05 vs. control at same distance). (C) ED1 profile for the control (open bars, n = 6) and 10EB + DS + GF group
(filled bars, n = 8) 2 weeks following implantation. The 10EB + DS + GF group exhibited a significant decrease in normalized
ED1 intensity at points immediately adjacent to the lesion border (*p > 0.05 vs. control at same distance). (D) ED1 profile for the
control (open bars, n = 6) and 10EB + GF no DS group (Black bars, n = 8) 2 weeks following implantation. The 10EB + GF no
DS group did not exhibited a significant different normalized ED1 intensity at any distance from the lesion border (p > 0.05). Error
bars represent SD.
surviving but are proliferating. Based on the initial esti- 4B). The analysis showed that the ESNPCs transplanted
in fibrin scaffolds containing the HBDS and GF (10EB +mate of 1 × 105 cells per 10EBs, in the two groups with-
out GF (10EB no Fibrin and 10EB + Fibrin) the number DS + GF) had an increase in the number of ESNPC-
derived NeuN-positive mature neurons (p < 0.05) (Fig. 5).of cells increased twofold [2.2 ± 1.1 × 105 and 2.0 ± 1.3 ×
105 cells, respectively (average ± SD)] and in the two
Differentiation of Transplanted ESNPCsgroups with GF (10EB + DS + GF and 10EB + GF no
DS) the number of cells increase roughly 100fold (12.0 ± Due to complications associated with acquiring accu-
rate counts of the remaining neural cell markers using6.8 × 105 and 10.0 ± 7.8 × 105 cells, respectively).
The groups receiving ESNPCs were also stained with stereology, a computer program was developed to quan-
tify the expression of neural markers. The total area ofthe neuronal nuclei marker NeuN, which identifies ma-
ture neurons. The NeuN staining revealed a population pixels positive for both GFP and the marker of interest
(Tuj1, GFAP, O4, nestin, or SSEA-1, staining shown inof ESNPCs that differentiated into mature neurons. The
differentiation was quantified using stereological counts Fig. 5) was measured in every 12th section in a series
of the number of cells positive for NeuN and GFP (Fig. of over 100 sections. The areas for each marker were
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Table 2. Presence of ESNPCs in the Spinal Cord After sion of the ESNPCs in fibrin containing GF with no
2 Weeks HBDS was not significantly different from any other
group.
ESNPCs With Two markers were used to evaluate the differentia-
at End ESNPCs
tion of ESNPCs into glia. The marker O4 was analyzedExperimental Transplants Point at End
to evaluate the differentiation of transplanted cells intoGroups (N) (N) Point
oligodendrocytes. O4 was expressed at considerably
10EB no Fibrin 6 3 50% lower levels compared to the neuronal marker Tuj1;
10EB + Fibrin 8 6 75% however, there were significant difference between
10EB + DS + GF 8 8 100% groups. The average area of O4 expression by ESNPC-
10EB + GF no DS 8 7 89% derived cells in fibrin with GF and HBDS (10EB + DS +
GF) was greater than all other groups (p < 0.05) (Fig.
7A). The expression of O4 by ESNPCs that were placed
directly in the lesion site (10EB no Fibrin) or embeddedthen averaged for each rat. The average area of GFP
expression for each experimental group was analyzed to in fibrin without GF (10EB + Fibrin) was very low. The
astrocytes marker GFAP was expressed by some ESNPC-compare this method of analysis with the stereological
results of GFP+ cells. As with the stereological data, the derived cells in each group. ESNPCs in fibrin with GF
(10EB + DS + GF and 10EB + GF no DS) had greaterESNPCs transplanted in fibrin with GF (10EB + DS +
GF and 10EB + GF no DS) had greater average areas of average areas of GFAP expression compared to ESNPCs
transplanted directly into the lesion site (10EB no Fi-GFP expression when compared to the ESNPCs trans-
planted alone (10EB no Fibrin) or the ESNPCs trans- brin) and ESNPCs in fibrin without GF (10EB + Fibrin)
(p < 0.05) (Fig. 7B). Finally, the expression of the NPCplanted in fibrin without GF (10EB + Fibrin) (p < 0.05)
(Fig. 6A). Analysis of another neuronal marker (Tuj1), marker nestin was used to evaluate those ESNPCs that
did not differentiate further and SSEA-1 was used tousing the average area of expression, showed similar
trends to those observed for the stereological counts of evaluate the presence of undifferentiated mouse embry-
onic stem cells. The average area of nestin expressionNeuN and GFP staining. The average area of Tuj1 ex-
pression was increased for the ESNPCs in fibrin con- did not reach the threshold for statistical significance for
differences between groups; however, when comparedtaining GF, and HBDS group (10EB + DS + GF) when
compared to ESNPCs transplanted alone (10EB no Fi- to ESNPCs transplanted directly into the lesion site,
there was a trend toward increased nestin expression forbrin) or ESNPCs in fibrin without GF (10EB + Fibrin)
(p < 0.05) (Fig. 6B). The average area of Tuj1 expres- the groups with GF (10EB + DS + GF, p = 0.056 and
Figure 4. Stereological counts of GFP-expressing ESNPCs and GFP-expressing ESNPCs that also expressed the neuronal marker
NeuN 2 weeks after transplantation. (A) A count of GFP-expressing ESNPCs was performed to analyze survival and proliferation
of the transplants from each experimental group. (Note: y-axis is multiplied by 105). The ESNPCs transplanted in fibrin scaffolds
containing NT-3 and PDGF (10EB + DS + GF (n = 8) and 10EB + GF no DS (n = 8)) had a significantly higher count of ESNPCs.
Error bars are SD. *p < 0.05 versus 10EB no Fibrin (n = 6) and 10EB + Fibrin (n = 8). (B) A count of GFP-expressing ESNPCs
that also expressed the marker for mature neurons, NeuN, was performed to analyze neuronal differentiation. (Note: y-axis is
multiplied by 104). The ESNPCs transplanted in fibrin scaffolds containing NT-3, PDGF, and the HBDS [10EB + GF + DS (n =
8)] had a significantly higher count of NeuN-positive ESNPCs when compared to ESNPCs transplanted alone (10EB no Fibrin)
and ESNPCs transplanted in fibrin scaffolds alone (10EB + Fibrin). Error bars represent SD. *p < 0.05 versus 10EB no Fibrin
(n = 6) and 10EB + Fibrin (n = 8).
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Figure 5. The figure depicts in vivo fluorescent imaging of transplanted cells 2 weeks following transplantation. (A) NeuN (red,
neuronal nuclei) staining showing the expression of NeuN by transplanted cells (GFP, green) cross-stained with Hoechst nuclear
stain (blue). (B) Tuj1 (red, neuronal cytoskeletal) staining showing the expression of Tuj1 by transplanted cells (GFP, green) cross-
stained with GFAP (blue, astrocytes). (C) Nestin (red, ESNPC) staining showing the expression of nestin by transplanted cells (GFP,
green) cross-stained with GFAP (blue, astrocytes). (D) O4 (red, early oligodendrocyte marker) staining showing the expression of
O4 by transplanted cells (GFP, green) cross-stained with GFAP (blue, astrocytes). (E) SSEA-1 (red, mouse embryonic stem cell
marker) staining showing the expression of SSEA-1 by transplanted cells (GFP, green) cross-stained with Ki67, the nuclear prolifer-
ation marker stain (blue). Scale bar: 100 µm.
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Figure 6. Average area of GFP and β-tubulin III (Tuj1) expression correlates with the stereological counts of GFP+ ESNPCs and
NeuN ESNPCs. (A) The average area of GFP expression was significantly larger in groups where the ESNPCs were transplanted
in fibrin scaffolds containing NT-3 and PDGF [10EB + DS + GF (n = 8) and 10EB + GF no DS (n = 8)] compared to ESNPCs
transplanted alone and in fibrin scaffolds [10EB no Fibrin (n = 6) and 10EB + Fibrin (n = 8)]. Error bars are SE. *p < 0.05 versus.
10EB no Fibrin and 10EB + Fibrin. (B) The average area of GFP and Tuj1 coexpression was significantly larger in the group
where ESNPCs were transplanted in fibrin scaffolds containing NT-3, PDGF, and the HBDS [10EB + DS + GF (n = 8)] when
compared to the 10EB no Fibrin and 10EB + Fibrin groups. Error bars represent SEM. *p < 0.05 versus 10EB no Fibrin (n = 6)
and 10EB + Fibrin (n = 8).
10EB + GF no DS, p = 0.07) (Fig. 7C). The average are SCI. The transplantation of ESNPCs in fibrin scaffolds
containing NT-3 and PDGF increased overall cell sur-of SSEA-1 expression was significantly greater when
ESNPCs were transplanted in a fibrin scaffold contain- vival and proliferation by X-fold over 2 weeks. Further-
more, the transplantation of ESNPCs in fibrin scaffoldsing the growth factors, and the HBDS when compared
to all other experimental groups (10EB + DS + GF vs. containing GF and HBDS increased the number of
ESNPC-derived NeuN+ neurons (1.2 × 105 NeuN+ cells10EB + GF no DS, 10EB no Fibrin, 10EB + Fibrin, p <
0.05) (Fig. 7D). in the 10EB + GF + DS group compared to <0.25 × 105
NeuN+ cells in the groups without GF). Others have
Macrophage/Microglia Profile found that NPC transplantation into the injured spinal
cord results in poor cell survival and differentiation intoThe host reaction to an implanted material can have
a significant effect on the intended function of the mate- a predominately glial fate (7,8,22,33). Previously, ESNPCs
induced using the same 4−/4+ RA protocol were in-rial. To evaluate the tissue response of the transplants, a
profile of macrophage/microglia presence adjacent to jected into a crush model of SCI 9 days after injury and
found to promote a modest increase in functional recov-the lesion site was used to assess inflammation. A pro-
gram was developed that analyzed the intensity of ED1 ery (21). However, the authors found that cell survival
was poor (10%), and few of the surviving cells differen-staining as a function of distance from the lesion border.
In all of the experimental groups, ED1-positive cells ac- tiated into neurons (8%). The findings in our current
study are significant because they demonstrate the abilitycumulated at the lesion border. The groups with ESNPCs
transplanted directly in the lesion site (10EB no Fibrin), to enhance the survival and differentiation of NPCs into
neurons after transplantation into the injured spinal cord.ESNPCS in fibrin (10EB + Fibrin), and ESNPCS in fi-
brin with GF and HBDS (10EB + DS + GF) exhibited a ESNPCs in fibrin scaffolds containing GF exhibited
robust survival and proliferation at 2 weeks followingdecrease in ED1 staining intensity compared to the un-
treated control group, immediately adjacent to the lesion implantation into a subacute model of SCI. In vitro stud-
ies evaluating NT-3 and PDGF, at the same total dosesborder (0 µm rostral and caudal, p < 0.05) (Fig. 3A).
There was no significant difference in ED1 intensity be- used in this study, found that the combination resulted
in increased survival of ESNPCs at 2 weeks (32). Con-tween the ESNPCs in fibrin with GF without HBDS
(10EB + GF no DS) when compared to the untreated sistent with these in vitro findings, our study found that
the stereological count of ESNPCs with GF (with orcontrol (p < 0.09) (Fig. 3B).
without HBDS) was higher than either ESNPCs im-
DISCUSSION planted directly into the lesion site or in fibrin without
GF after transplantation. The stereological counts esti-The in vivo survival and differentiation of trans-
planted ESNPCs was evaluated in a subacute model of mate that the addition of GF increased the total cell
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Figure 7. The conditions for ESNPC transplantation had a significant effect of differentiation. (A) The average area of GFP and
O4 coexpression for ESNPCs that differentiated into oligodendrocytes was significantly increased in ESNPCs transplanted within
fibrin scaffolds containing NT-3, PDGF, and the HBDS [10EB + DS + GF (n = 8)] compared to all other groups [*p < 0.05 com-
pared to 10EB no Fibrin (n = 6), 10EB + Fibrin (n = 8), and 10EB + GF no DS (n = 8)]. (B) The average area of GFP and GFAP
coexpression for ESNPCs that differentiated into astrocytes was significantly increased in ESNPCs transplanted within fibrin scaf-
folds containing NT-3 and PDGF [10EB + DS + GF (n = 8) and 10EB + GF no DS (n = 8)] compared to ESNPCs transplanted
alone and in fibrin scaffolds [10EB no Fibrin (n = 6) and 10EB + Fibrin (n = 8)] [*p < 0.05 vs. 10EB no Fibrin (n = 6) and 10EB +
Fibrin (n = 8)]. (C) The average area of GFP and nestin coexpression for ESNPCs remained undifferentiated was not significantly
between all of the groups. (D) The average area of GFP and SSEA-1 coexpression for transplanted mouse embryonic stem cells
that remained undifferentiated was significantly greater when transplanted in fibrin scaffolds containing growth factor and the
HBDS when compared to all other experimental groups (*p < 0.05 vs. 10EB no Fibrin, 10EB + fibrin, and 10EB + DS + GF). Error
bars from all graphs represent SEM.
number approximately 10-fold over the initial estimated percentage ESNPCs that differentiated into neurons
(32). It has been shown that soluble NT-3 promotes thecell number in 2 weeks. In contrast, those ENSPCs em-
bedded in fibrin scaffolds alone only increased roughly differentiation of human ESCs into neurons in culture
and treatment of NPCs with NT-3 results in the forma-twofold over the same time period. Our findings are
consistent with other studies that have shown that the tion of bipolar neurons (19,20). The stereological count
of NeuN+ neurons derived from ESNPCs in fibrin withcombination of NT-3 and PDGF promotes NPC survival
in models of CNS disease (14), and PDGF specifically GF and no HBDS was not different from the other
groups. These results suggest that controlled delivery ofpromotes NPC proliferation (11,12).
The incorporation of the HBDS in fibrin scaffolds NT-3 and PDGF using the HBDS was required for the
increase in neuronal differentiation compared groupscontaining GF and ESNPCs resulted in an increase in
the number of ENSPC-derived NeuN+ cells. These find- without GF.
The addition of the HBDS could have affected theings are consistent with in vitro studies that found NT-
3 and PDGF delivered from the HBDS increased the differentiation of the ESNPCs. Heparin alone in the cul-
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ture medium of ESCs and NPCs has been shown to in- pected. However, this method does not allow correla-
tions between markers (e.g., area of Tuj1 vs. GFAP) thatcrease proliferation through secondary interactions with
fibroblast growth factor (FGF) that enhance FGF’s mi- could be performed with absolute cell number counts
from stereology.totic activity (5,15). Willerth et al. found that using the
same concentration of heparin found in the HBDS re- By analyzing the average area of GFP+ O4 expression
using this method, we found that ESNPC-derived cellssulted in a decrease in astrocytes differentiation (32). In
our study, the HBDS had no effect on astrocytes differ- in fibrin with GF and the HBDS showed increased O4
expression compared to all other groups. The combina-entiation of ESNPCs, and thus it is unlikely that direct
interaction between heparin and the ESNPCs resulted in tion of the two GF and the HBDS was found to increase
oligodendrocyte differentiation in vitro ESNPCs (32).an increase in NeuN+ neurons.
As with heparin, the presence of the heparin-binding The increased O4 expression seen in the 10EB + DS +
GF group suggests that the presence of the controlledpeptide from the HBDS could have an effect on ESNPCs
differentiation. Others have demonstrated the ability of delivery of GF promotes oligodendrocyte differentia-
tion. ESNPCs in fibrin containing GF with or withoutcell adhesion sequences from laminin to promote differ-
entiation of NPCs (28). However, evaluation of the HBDS showed an increase in the average area of GFAP
expression compared to groups without GF. In vitroHBDS in vitro showed that the affinity peptide alone in
culture had no effect on neuronal differentiation (32). studies found that the addition of the HBDS decreased
astrocytes differentiation compared to controls that wereBased on these previous results, it is unlikely that inter-
action of ESNPCs with the heparin-binding peptide in cultured without the GF (32). While the addition of the
GF resulted in increased GFAP and O4 staining, thethe HBDS accounted for the increase in NeuN+ neurons.
A more likely explanation for the observed increase in neuronal markers were more widely expressed than glial
markers on ESNPC-derived cells after transplantation.NeuN+ neurons with the HBDS is its ability to sequester
NT-3 and PDGF to the fibrin scaffold (29,32). Further- Staining with the mouse ESC marker SSEA-1 re-
vealed a moderate amount of expression of the ESCmore, the HBDS could also have increased the residence
time of other endogenously produced GFs within the fi- marker by the transplanted cells. This is not surprising
considering the RA induction protocol only results in abrin scaffolds.
A method to analyze the differentiation of trans- population of cells that are 70% nestin-positive ESNPCs
(31). Quantification of the average area of SSEA-1 ex-planted ESNPCs was developed to compliment the ste-
reological analysis performed in this study. With the ex- pression revealed differences between experimental
groups. The 10EB + DS + GF group average are of SSEA-ception of NeuN, the cell differentiation markers used in
this study were cell surface (SSEA-1/O4) or intracellular 1 expression was greater than all other experimental
groups. Previously, it has been shown that PDGF canproteins (nestin, Tuj1, GFAP) that are expressed in dif-
ferent locations within the cell. As a consequence, if the enhance the survival and proliferation of SSEA-1-posi-
tive mouse ESCs in in vitro culture (31). It follows thatcell of interest is adjoining another cell with the same
marker it is difficult to delineate the boundary between in this study the presence of the growth factors and the
HBDS enhanced the survival and proliferation of SSEA-each independent cell and thus impossible to make an
accurate stereological count. A program was written that 1-positive mouse ESCs.
Analysis of the average area of marker expression isevaluates the total area of pixels that are positive for
both green fluorescent protein (GFP) and the neural not the same as stereological counts of cells. As men-
tioned above, the quantification of proteins that are lo-marker of interest. While this method of analysis does
not indicate a specific number of cells stained positive cated in different places within the cell make compari-
son of areas between different antibodies inaccuratefor a given marker, it does quantify the average area of
expression for each given marker. The area of expres- (e.g., area positive for Tuj1 vs. GFAP). Likewise, the
summation of the different average areas of expressionsion can then be compared between experimental groups
to determine a difference in expression between groups. (Tuj1, GFAP, nestin, and SSEA-1) are not expected to
add up to the average area of expression of GFP+ trans-To assure that the method correlated to the stereological
counts of the GFP+ and NeuN+ cells, we analyzed the planted ESNPCs and they do not. It is possible that the
differences in area are a result of the quantificationamount of GFP expression for transplanted ESNPCs and
Tuj1 for neurons. The analysis of average area of ex- method and it is possible that some of the GFP+ cells
are expressing markers other than those assayed in thispression for GFP and Tuj1 predicted the same trends
obtained with the stereological counts for transplanted study. Based on the type of analysis that was utilized in
this study, it is impossible to tell. However, the goal ofESNPCs that expressed the neuronal marker NeuN and
GFP; thus, for a given marker a greater area of expres- the analysis was to look at the differential effects these
growth factors have on differentiation of the ESNPCssion correlated with a greater number of cells, as ex-
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